Research report
Anti-acetylcholine receptor antibodies in myasthenia gravis: Part 2. Clinical and serological follow-up of individual patients

https://doi.org/10.1016/0022-510X(83)90096-5Get rights and content

Abstract

Circulating antibodies to acetylcholine receptor protein (anti-AChR) were measured in the sera collected from 75 patients (53 women, 22 men, ages 9–83 year, 20 with a thymoma) with myasthenia gravis (MG) during 5–44 (mean 25) months. The clinical state of each patient was graded on a 6-point scale. Anti-AChR concentrations were measured by a radioimmunoassay with human antigen. We analysed the relation between the change in clinical state and the change in anti-AChR concentration in 155 periods (1–7, mean 2.1 per patient). The change in clinical state is given as the difference in score at the onset and at the end of this period. The change in anti-AChR concentration is expressed as the percentage of the original concentration at the onset of the period.

The results were analysed in relation to the therapy and to the severity of the MG at the onset of each period. A strong correlation between a change in anti-AChR concentration and a change in clinical condition existed during treatment with prednisone or immunosuppression and in the period after thymectomy, while a weaker correlation was present in periods without immunosuppression. In only 3 patients did the changes in anti-AChR concentration preceed the clinical change. No changes in anti-AChR concentrations were found if improvement was due to the effect of anticholinesterases or if deterioration was caused by infection or emotion. The serial measurement of anti-AChR may be a valuable method of following the basic trend of the MG in severely affected patients.

References (32)

  • P.C. Limburg et al.

    Anti-acetylcholine receptor antibodies in myasthenia gravis, Part I (Relation to clinical parameters in 250 patients)

    J. neurol. Sci.

    (1983)
  • H.J.G.H. Oosterhuis

    Myasthenia gravis — A review

    Clin. Neurol. Neurosurg.

    (1981)
  • P. Wijermans et al.

    Thymus-dependent serum factor in nonthymectomized and thymectomized patients with myasthenia gravis

    Clin. Immunol. Immunopath.

    (1980)
  • E. Bartoccioni et al.

    Myasthenia gravis, thymectomy and antiacetylcholine receptor antibody

    J. Neurol.

    (1980)
  • K.A. Besinger et al.

    Long term correlation of clinical course and acetylcholine receptor antibody in patients with myasthenia gravis

    Ann. N.Y. Acad. Sci.

    (1981)
  • R.J. Bradley et al.

    Humoral immunity in myasthenia gravis — Relationship to disease severity and steroid treatment

  • B. Carter et al.

    Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy

    J. Neurol. Neurosurg. Psychiat.

    (1980)
  • S. Cuénod et al.

    Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis

    Neurology (Minneap.)

    (1980)
  • P.C. Dau

    Plasmapheresis therapy in myasthenia gravis

    Muscle & Nerve

    (1980)
  • S.B. Elias et al.

    Neonatal myasthenia gravis in the infant of a myasthenic mother in remission

    Ann. Neurol.

    (1979)
  • A.G. Engel

    The immunopathology of acquired myasthenia gravis

  • J. Keesey et al.

    Anti-acetylcholine receptor antibody in neonatal myasthenia gravis

    N. Engl. J. Med.

    (1977)
  • J. Keesey et al.

    Plasma exchange alone as therapy for myasthenia gravis

    Ann. N.Y. Acad. Sci.

    (1981)
  • P. Kornfeld et al.

    Acetylcholine receptor antibodies in myasthenia gravis

    Muscle & Nerve

    (1981)
  • A.K. Lefvert et al.

    Determination of acetylcholine receptor antibody in myasthenia gravis - Clinical usefulness and pathogenic implications

    J. Neurol. Neurosurg. Psychiat.

    (1978)
  • P.C. Limburg et al.

    Relationship between changes in anti-acetylcholine receptor concentration and disease severity in myasthenia gravis

    Ann. N.Y. Acad. Sci.

    (1982)
  • Cited by (0)

    View full text